Last reviewed · How we verify
BAY1747846
At a glance
| Generic name | BAY1747846 |
|---|---|
| Sponsor | Bayer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Tinnitus
- Injection site bruising
- Dermatitis contact
- Toothache
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BAY1747846 CI brief — competitive landscape report
- BAY1747846 updates RSS · CI watch RSS
- Bayer portfolio CI